Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT04352478What this trial is testingIncidental Cancer in Gallbladder Surgical Specimens Focus on Elderly PatientsWho this might be right forPathology Dr. Ersin Arslan Education and Training Hospital 2,389
Testing effectiveness (Phase 2)Ended earlyNCT00023946What this trial is testingBMS-247550 in Treating Patients With Liver or Gallbladder CancerWho this might be right forAdult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00005997What this trial is testingRebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Case Comprehensive Cancer Center 72
Testing effectiveness (Phase 2)Study completedNCT00005938What this trial is testingDX-8951f in Treating Patients With Biliary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00009893What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Alliance for Clinical Trials in Oncology 42
Not applicableStudy completedNCT00489515What this trial is testingVisceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderWho this might be right forColorectal CancerGallbladder CancerGastric Cancer+2 more Wake Forest University Health Sciences 115
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)Study completedNCT01766219What this trial is testingCPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By SurgeryWho this might be right forAdult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+6 more Wake Forest University Health Sciences 17
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Study completedNCT00033462What this trial is testingErlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder CancerWho this might be right forAdult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+8 more National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)UnknownNCT00003296What this trial is testingLiposomal Doxorubicin in Treating Patients With Liver or Bile Duct CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Brown University 26
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Early research (Phase 1)Study completedNCT00544193What this trial is testingGemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more City of Hope Medical Center 16
Large-scale testing (Phase 3)Study completedNCT01313377What this trial is testingGemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by SurgeryWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer UNICANCER 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT04308174What this trial is testingNeoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract CancerWho this might be right forBiliary Tract NeoplasmsGallbladder CancerCholangiocarcinoma Asan Medical Center 45